These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

Your kidneys are working tirelessly throughout the day to keep your system clean from unwanted waste products and fluids.

Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

More than 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, ...

Chronic health conditions are having a serious, negative impact on the welfare of the country's workers and their output, a ...

Semaglutide is now approved for reducing the risk for worsening kidney disease and cardiovascular death in adults with ...

Chronic kidney disease (CKD) is a progressive renal disease that causes kidney function to deteriorate. It appears as urinary ...

A well-known class of drugs used to manage type 2 diabetes and control weight could offer hope for patients who also struggle ...

The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease, and cardiovascular ...

The FDA has approved popular antiobesity drug Ozempic to help protect patients with type 2 diabetes from kidney disease.

It also reduced the risk of kidney failure and cut the risk of death from heart disease by about 5% in adults with both type 2 diabetes and chronic kidney disease, the company said in a news release.

Dialysis Centers used data from the Centers for Disease Control and Prevention to examine the prevalence of chronic diseases ...